187 related articles for article (PubMed ID: 16149601)
21. [Use of tumor marker CA50].
Wøldike PM; Charib K; Siboni A
Ugeskr Laeger; 2008 Sep; 170(38):2985; author reply 2986. PubMed ID: 18816889
[No Abstract] [Full Text] [Related]
22. [Tumor markers in the diagnosis of tumors in the subhepatic area].
Dufek V; Petrtýl J; Klener P; Chmel J
Vnitr Lek; 1994 Jun; 40(6):350-3. PubMed ID: 8073643
[TBL] [Abstract][Full Text] [Related]
23. [Tumor markers in the early diagnosis of recurrence in gynecologic neoplasms: combined determination of CA-125, CA 15-3, CA 72.4, SCC, 90 K].
Garzetti GC; Di Lauro RM; Ciavattini A; Pallotta MR; Marchegiani F; Valensise H; Tranquilli AL; Arduini D; Romanini C
Ann Ostet Ginecol Med Perinat; 1991; 112(5):320-3. PubMed ID: 1817444
[TBL] [Abstract][Full Text] [Related]
24. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
[TBL] [Abstract][Full Text] [Related]
25. [The diagnostic value of determining the level of the carbohydrate antigen 19-9 in pancreatic cancer].
Moroz GS; Les'kiv IM
Klin Khir (1962); 1993; (2):34-5. PubMed ID: 10912065
[TBL] [Abstract][Full Text] [Related]
26. [GAT (galactosyltransferase associated with tumor)].
Fukuchi T; Nozawa S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():726-9. PubMed ID: 16149624
[No Abstract] [Full Text] [Related]
27. [The pre- and postoperative and follow-up use of the tumor markers MCA, CA-125 and CA-19-9].
Zanon C; Alluminio P; Margarita V; Sottimano C; Giuliani F; Neri G; Ballario F
Minerva Chir; 1992 Jan; 47(1-2):27-30. PubMed ID: 1553049
[TBL] [Abstract][Full Text] [Related]
28. [Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].
Sugano K; Okura H
Nihon Rinsho; 1990 Feb; 48 Suppl():1031-4. PubMed ID: 2192105
[No Abstract] [Full Text] [Related]
29. [Gamma-seminoprotein (gamma-Sm)].
Miyahara S
Nihon Rinsho; 2005 Aug; 63 Suppl 8():698-701. PubMed ID: 16149615
[No Abstract] [Full Text] [Related]
30. [Carcinoembryonic antigen (CEA)].
Kinugasa T; Kuroki M
Nihon Rinsho; 2005 Aug; 63 Suppl 8():632-4. PubMed ID: 16149597
[No Abstract] [Full Text] [Related]
31. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
Okamoto T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():765-7. PubMed ID: 16149635
[No Abstract] [Full Text] [Related]
32. Comparison of tumor marker CA 242 with CA 19-9 and carcinoembryonic antigen (CEA) in pancreatic cancer.
Ozkan H; Kaya M; Cengiz A
Hepatogastroenterology; 2003; 50(53):1669-74. PubMed ID: 14571813
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of serum CA 19-9 in malignant tumors.
Ding HJ; Wu CC; Yang CC; Her SS; Wu LL; Ker CG; Huang TJ
Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Jun; 3(6):400-6. PubMed ID: 2838648
[No Abstract] [Full Text] [Related]
34. [Pancreatic cancer screening: mission impossible?].
Bartel M; Friess H
Z Gastroenterol; 2006 Nov; 44(11):1181-2. PubMed ID: 17115361
[No Abstract] [Full Text] [Related]
35. Breast cancer mucin antigen (BCM) determination by IMX: a preliminary study of epidemiological distribution of the serum levels in gynecological diseases.
Torre GC; Barbetti V; Lanfranco E; Robutti M; Foglia M; Corongiu F; Vigliercio GP
J Nucl Med Allied Sci; 1990; 34(4 Suppl):59-62. PubMed ID: 2092151
[No Abstract] [Full Text] [Related]
36. Use of multiple markers to enhance clinical utility.
Mercer DW
Immunol Ser; 1990; 53():39-54. PubMed ID: 2100569
[No Abstract] [Full Text] [Related]
37. [SLX (sialyl SSEA-1, sialyl Le(x)-i)].
Kannagi R; Izawa M; Koike T
Nihon Rinsho; 2005 Aug; 63 Suppl 8():675-80. PubMed ID: 16149609
[No Abstract] [Full Text] [Related]
38. Comparison of CA19-9 with other tumor markers in the diagnosis of cancer of the pancreas.
Satake K; Takeuchi T
Pancreas; 1994 Nov; 9(6):720-4. PubMed ID: 7846015
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of RCAS1 as serum tumor marker for pancreatic cancer].
Yang YC; Zhao YP; Liao Q; Zhang TP; Hu Y; Dai MH
Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(13):999-1001. PubMed ID: 19957811
[TBL] [Abstract][Full Text] [Related]
40. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
